Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 121.00
-1.50 (-1.22%)
Aug 5, 2025, 1:30 PM CST
Sage Therapeutics Market Cap
TPE:6919 has a market cap or net worth of 190.00 billion as of August 4, 2025. Its market cap has increased by 120.16% in one year.
Market Cap
190.00B
Enterprise Value
180.46B
Revenue
40.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
$121.00
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 190.00B, an increase of 2,287.41%. That is a compound annual growth rate of 237.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 190.00B | 101.35% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 166.13B |
| Bora Pharmaceuticals Co., LTD. | 86.62B |
| Lotus Pharmaceutical | 57.85B |
| Oneness Biotech | 29.99B |
| Polaris Group | 27.89B |
| Center Laboratories | 26.60B |
| Pegavision | 24.53B |
| TaiMed Biologics | 22.67B |